55 filings
8-K
KRTX
Karuna Therapeutics Inc
18 Mar 24
Completion of Acquisition or Disposition of Assets
9:04am
8-K
KRTX
Karuna Therapeutics Inc
14 Mar 24
Other Events
7:26am
8-K
KRTX
Karuna Therapeutics Inc
12 Mar 24
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
KRTX
Karuna Therapeutics Inc
1 Mar 24
Other Events
6:01am
8-K
KRTX
Karuna Therapeutics Inc
22 Feb 24
Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update
6:32am
8-K
lgpbtiw 2cz9gkf192f1
16 Jan 24
Departure of Directors or Certain Officers
4:18pm
8-K
80k3byz 5xs8cihim
22 Dec 23
Entry into a Material Definitive Agreement
5:07pm
8-K
bn4vxhesoy9s1u5r3
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
8:26am
8-K
bbnwcc xas9hz869ms9
2 Nov 23
Karuna Therapeutics Reports Third Quarter 2023 Financial Results and Provides General Business Updates
6:36am
8-K
iijzx d2z2kmei1ce81e
3 Aug 23
Karuna Therapeutics Reports Second Quarter 2023 Financial Results and Provides General Business Updates
6:37am
8-K
67lllkwh4w9tn egr
21 Jun 23
Termination of a Material Definitive Agreement
4:05pm
8-K
7cd us5uu
4 May 23
Karuna Therapeutics Reports First Quarter 2023 Financial Results and Provides General Business Updates
6:37am
8-K
7bsk8
22 Mar 23
Karuna Therapeutics Announces Proposed Public Offering of Common Stock
5:23pm
8-K
a4t w5ij17ga9
20 Mar 23
Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia
6:59am
8-K
p0yxexvpzvza
10 Mar 23
Regulation FD Disclosure
3:53pm
8-K
y230f9u xqi5121u
23 Feb 23
Karuna Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Result and Provides General Business Updates
6:36am
8-K
tbhnnh61cwr8
2 Feb 23
Karuna Therapeutics Announces Exclusive Global License Agreement for Goldfinch Bio’s Investigational TRPC4/5 Product Candidates
6:40am
8-K
if5jcqz
5 Jan 23
Departure of Directors or Certain Officers
4:32pm
8-K
5rg5d 5k5yi
6 Dec 22
Karuna Therapeutics Appoints Bill Meury as President and Chief Executive Officer
6:36am
8-K
od3axot0a0a 64s8cd
3 Nov 22
Karuna Therapeutics Reports Third Quarter 2022 Financial Results and Provides General Business Updates
6:37am